National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 21866-21867 [2020-08283]
Download as PDF
<![CDATA[
21866
Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices
special assistance or other reasonable
accommodations to view the meeting,
should notify the Contact Person listed
below in advance of the meeting. The
open session will be videocast and can
be accessed from the NIH Videocasting
and Podcasting website (https://
videocast.nih.gov/).
A portion of this will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSKJLSW7X2PROD with NOTICES
Name of Committee: National Advisory
Council on Drug Abuse.
Date: May 12, 2020.
Closed: 11:00 a.m. to 12:15 p.m.
Agenda: To review and evaluate grant
applications.
Open: 12:45 p.m. to 4:30 p.m.
Agenda: Presentations and other business
of the Council.
Place: National Institutes of Health,
National Institute on Drug Abuse,
Neurosciences Center Building, 6001
Executive Boulevard, Rockville, MD 20852,
(Virtual Meeting).
Contact Person: Susan R.B. Weiss, Ph.D.,
Director, Division of Extramural Research,
Office of the Director, National Institute on
Drug Abuse, NIH, DHHS, 6001 Executive
Boulevard, NSC, Room 5274, MSC 9591,
Rockville, MD 20892, 301–443–6487,
sweiss@nida.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page:
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: April 13, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–08196 Filed 4–17–20; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:34 Apr 17, 2020
Jkt 250001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Asthma
Education Prevention Program
Coordinating Committee.
The meeting will be open to the
public at the WebEx link below.
Individuals wishing to attend should
refer to the information listed below on
the Institute’s/Center’s home page for
any additional information as the
meeting approaches.
Name of Committee: National Asthma
Education Prevention Program Coordinating
Committee.
Date: May 13, 2020.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: Welcome, Guidelines Update and
Implementation, and Future Directions/Role
of NAEPPCC.
Place: National Institutes of Health,
Rockledge I, 6705 Rockledge Drive, Bethesda,
MD 20892 (Virtual Meeting).
Telephone Access: 1–650–479–3208,
Access Code: 625 290 665.
Virtual Access: WebEx Link: https://
nih.webex.com/nih/j.php?MTID=
m214553b59a41098134407ebe13ebcf87;
Event number (access code): 299 510 569,
Event password: Asthma; Event Call-in toll
number (US/Canada): 1–650–479–3208.
Contact Person: Susan Shero, BSN, MS,
Program Officer, CTRIS, Center for
Translational Research and Implementation
Science, National Heart, Lung and Blood
Institute, National Institutes of Health, 6705
Rockledge Drive, Room 401–H2, Bethesda,
MD 20892, 301–496–1051, susan.shero@
nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nhlbi.nih.gov/advisory-and-peerreview-committees/national-asthmaeducation-and-prevention-programcoordinating, where an agenda and any
additional information for the meeting will
be posted when available. A summary of the
draft Asthma Guidelines will be posted to the
website prior to the meeting. Public
disclosure of the actual draft Guidelines, at
this point in the process, risks the
distribution of content, which includes
recommendations for medical care, causing
potential confusion among those for whom
the guidelines are intended to assist. This
would likely significantly frustrate
implementation of final Guidelines expected
to be released later this year.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: April 14, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–08280 Filed 4–17–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; RFA DK19–506:
Limited Competition: Competitive
Supplement to the Coordinating Center for
T1D TrialNet (U01 Clinical Trial Required).
Date: May 27, 2020.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Najma S. Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7349, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
E:\FR\FM\20APN1.SGM
20APN1
Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices
Dated: April 15, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2020–08283 Filed 4–17–20; 8:45 am]
National Cancer Institute; Notice of
Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSKJLSW7X2PROD with NOTICES
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Preclinical Services for HIV
Therapeutics (Task Area G).
Date: May 11, 2020.
Time: 12:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G33,
Rockville, MD 20892, (Telephone Conference
Call).
Contact Person: David C. Chang, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G33, Rockville 20852,
301–594–4218, dchang4@gmail.com.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 13, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–08194 Filed 4–17–20; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
18:34 Apr 17, 2020
Jkt 250001
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; NCI
Transition Career Development Award.
Date: May 19, 2020.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W234, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W234, Bethesda, MD 20892–9750, 240–276–
6368, Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute, Initial Review Group;
Subcommittee F—Institutional Training and
Education.
Date: June 9, 2020.
Time: 1:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W234, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W234, Bethesda, MD 20892–9750, 240–276–
6368, Stoicaa2@mail.nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; Collection
of Biospecimens and Epidemiologic Profiles.
Date: June 12, 2020.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
21867
7W608, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, 9609
Medical Center Drive, Room 7W608, National
Cancer Institute, NIH, Bethesda 20892–9745,
240–276–5856, nadeem.khan@nih.gov.
Name of Committee: National Cancer
Institute, Initial Review Group;
Subcommittee J—Career Development.
Date: June 18–19, 2020.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Shady Grove Medical Center, 9609
Medical Center Drive, Room 7W624,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Tushar Deb, Ph.D.,
Scientific Review Officer, Resources &
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W624, Rockville, MD 20850, 240–
276–6132, tushar.deb@nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; Moonshot:
Inherited Cancer Syndromes.
Date: June 19, 2020.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W106, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Reed A. Graves, Ph.D.,
Scientific Review Officer, 9609 Medical
Center Drive, Room 7W106, Division of
Extramural Activities, Research Technology
and Contract Review Branch, National
Cancer Institute, NIH, Rockville, MD 20850,
240–276–6384, gravesr@mail.nih.gov.
Name of Committee: National Cancer
Institute, Special Emphasis Panel; Ruth L.
Kirschstein National Research Service Award
(NRSA), Institutional Research Training
Grant.
Date: June 30, 2020.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W234, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W234, Bethesda, MD 20892–9750, 240–276–
6368, Stoicaa2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
E:\FR\FM\20APN1.SGM
20APN1
]]>Agencies
[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Pages 21866-21867]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08283]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; RFA DK19-506: Limited
Competition: Competitive Supplement to the Coordinating Center for
T1D TrialNet (U01 Clinical Trial Required).
Date: May 27, 2020.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Najma S. Begum, Ph.D., Scientific Review
Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
Room 7349, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301)
594-8894, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
[[Page 21867]]
Dated: April 15, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-08283 Filed 4-17-20; 8:45 am]
BILLING CODE 4140-01-P
